Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × envafolimab × Clear all

NCT05828381 2023-04-25

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms